Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension

BMC Genetics

Volumn 12, Issue , 2011, Pages

  Fenger, Mogens ^a   Linneberg, Allan ^b   Jørgensen, Torben ^b   Madsbad, Sten ^a   Søbye, Karen ^a   Eugen Olsen, Jesper ^a   Jeppesen, Jørgen ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; SPHINGOSINE 1 PHOSPHATE; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC EPISTASIS; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POPULATION; SUPINE POSITION; SYNTHESIS; SYSTOLIC BLOOD PRESSURE; BIOLOGICAL MODEL; BLOOD PRESSURE; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

BLOOD PRESSURE; CERAMIDES; EPISTASIS, GENETIC; FEMALE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LYSOPHOSPHOLIPIDS; MALE; MODELS, GENETIC; SPHINGOSINE;

EID: 79955812492     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/1471-2156-12-44     Document Type: Article

References (53)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
2. Johns DG, Dorrance AM, Leite R, Weber DS, Webb RC. Novel signaling pathways contributing to vascular changes in hypertension. J Biomed Sci 2000, 7:431-443. 10.1007/BF02253359, 11060492.
3. Rosskopf D, Schurks M, Rimmbach C, Schafers R. Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol 2007, 374:429-469. 10.1007/s00210-007-0133-2, 17262198.
4. Williams SS. Advances in genetic hypertension. Curr Opin Pediatr 2007, 19:192-198. 10.1097/MOP.0b013e32801e217c, 17496764.
5. Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008, 148:102-110.
6. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007, 49:432-438. 10.1161/01.HYP.0000256956.61872.aa, 17242302.
7. Singer GM, Setaro JF. Secondary hypertension: obesity and the metabolic syndrome. J Clin Hypertens (Greenwich) 2008, 10:567-574.
8. Shih PA, O'Connor DT. Hereditary determinants of human hypertension: strategies in the setting of genetic complexity. Hypertension 2008, 51:1456-1464. 10.1161/HYPERTENSIONAHA.107.090480, 2587105, 18413494.
9. Weder AB. Genetics and hypertension. J Clin Hypertens (Greenwich) 2007, 9:217-223.
10. Hamet P, Seda O. Current status of genome-wide scanning for hypertension. Curr Opin Cardiol 2007, 22:292-297. 10.1097/HCO.0b013e328187b502, 17556880.
11. Deng AY. Genetic basis of polygenic hypertension. Hum Mol Genet 2007, 16(Spec No. 2):R195-R202.
12. WTCCC Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. 10.1038/nature05911, 2719288, 17554300, WTCCC.
13. Ehret GB, Morrison AC, O'Connor AA, Grove ML, Baird L, Schwander K, et al. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program. Eur J Hum Genet 2008, 1507-1511.
14. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009, 5:e1000564. 10.1371/journal.pgen.1000564, 2702100, 19609347.
15. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009,
16. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, advanced online publication.
17. Fenger M, Linneberg A, Werge T, Jorgensen T. Analysis of heterogeneity and epistasis in physiological mixed populations by combined structural equation modelling and latent class analysis. BMC Genet 2008, 9:43. 2483291, 18611252.
18. Hemmings DG. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol 2006, 373:18-29. 10.1007/s00210-006-0046-5, 16570136.
19. Igarashi J, Thatte HS, Prabhakar P, Golan DE, Michel T. Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci USA 1999, 96:12583-12588. 10.1073/pnas.96.22.12583, 22998, 10535965.
20. Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, et al. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 2002, 106:2250-2256. 10.1161/01.CIR.0000035650.05921.50, 12390956.
21. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 2003, 58:170-177. 10.1016/S0008-6363(03)00260-8, 12667959.
22. Alewijnse AE, Peters SLM. Sphingolipid signalling in the cardiovascular system: Good, bad or both?. European Journal of Pharmacology 2008, 585:292-302. 10.1016/j.ejphar.2008.02.089, 18420192.
23. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999, 353:1547-1557. 10.1016/S0140-6736(99)04021-0, 10334252.
24. Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987, 126:912-921.
25. Rasmussen SL, Torp-Pedersen C, Borch-Johnsen K, Ibsen H. Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey. J Hypertens 1998, 16:1415-1424. 10.1097/00004872-199816100-00004, 9814611.
26. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113:664-670. 10.1161/CIRCULATIONAHA.105.579342, 16461839.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
28. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006, 19:243-250. 10.1016/j.amjhyper.2005.09.018, 16500508.
29. Karmakar R, Bose I. Stochastic model of transcription factor-regulated gene expression. Phys Biol 2006, 3:200-208. 10.1088/1478-3975/3/3/005, 17021384.
30. Muthen LK, Muthen BO. Mplus User's Guide 2004, Los Angeles, CA. Muthén & Muthén, Third.
31. Olsson UH, Foss T, Troye SV, Howell RD. The performance of ML, GLS, and WLS estimation in structural equation modeling under conditions of misspecification and nonnormality. Struct Eq Model 2000, 7:557-595.
32. Fenger M. Modelling genetic and physiological heterogeneity. Genetic inheritance patterns 2008, 75-123. Nova Science Publisher, Kimura R.
33. McLachlan G, Peel D. Finite mixture models 2000, John Wiley & Sons.
34. Lynch M, Walsh B. Genetics and Analysis of Quantitative Traits 1998, Sinauer.
35. Zeng ZB, Wang T, Zou W. Modeling Quantitative Trait Loci and Interpretation of Models. Genetics 2005, 169:1711-1725. 1449562, 15654105.
36. Wang T, Zeng ZB. Models and partition of variance for quantitative trait loci with epistasis and linkage disequilibrium. BMC Genet 2006, 7:9. 1456990, 16472377.
37. Junker BH, Koschutzki D, Schreiber F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 2006, 7:219. 10.1186/1471-2105-7-219, 1524990, 16630347.
38. Batagelj V, Mrvar A. Pajek - Progamme for Large Network Analysis. 2009,
39. Excoffier L, Laval LG, Schneider S. Arlequin ver. 3.01: An integrated software package for population genetics. Evolutionary Bioinformatics Online 2005, 1:47-50. 2658868, 19325852.
40. Thode HC. Testing for normality 2002, Marcel Dekker, New York.
41. Bagdade JD, Buchanan WF, Pollare T, Lithell H. Abnormal lipoprotein phospholipid composition in patients with essential hypertension. Atherosclerosis 1995, 117:209-215. 10.1016/0021-9150(95)05573-F, 8801866.
42. Ichi I, Nakahara K, Miyashita Y, Hidaka A, Kutsukake S, Inoue K, et al. Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids 2006, 41:859-863. 10.1007/s11745-006-5041-6, 17152923.
43. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008, 9:139-150. 10.1038/nrm2329, 18216770.
44. Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 2009, 30:86-98. 10.1016/j.mam.2008.08.009, 2714364, 18812186.
45. Dorogovtsev SN, Goltsev AV, Mendes JF. Correlations in interacting systems with a network topology. Phys Rev E Stat Nonlin Soft Matter Phys 2005, 72:066130.
46. Grassme H, Riethmuller J, Gulbins E. Biological aspects of ceramide-enriched membrane domains. Progress in Lipid Research 2007, 46:161-170. 10.1016/j.plipres.2007.03.002, 17490747.
47. Levy M, Castillo SS, Goldkorn T. nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem Biophys Res Commun 2006, 344:900-905. 10.1016/j.bbrc.2006.04.013, 16631623.
48. Rovina P, Schanzer A, Graf C, Mechtcheriakova D, Jaritz M, Bornancin F. Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions together with C-terminal domains. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009, 1791:1023-1030.
49. Tuson M, Garanto A, Gonzalez-Duarte R, Marfany G. Overexpression of CERKL, a gene responsible for retinitis pigmentosa in humans, protects cells from apoptosis induced by oxidative stress. Mol Vis 2009, 15:168-180. 2628313, 19158957.
50. Carlborg O, Jacobsson L, Ahgren P, Siegel P, Andersson L. Epistasis and the release of genetic variation during long-term selection. Nat Genet 2006, 38:418-420. 10.1038/ng1761, 16532011.
51. Yoshimura S, Banno Y, Nakashima S, Hayashi K, Yamakawa H, Sawada M, et al. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. J Neurochem 1999, 73:675-683.
52. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309. 10.1038/ng749, 11600885.
53. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006, 25:127-141. 10.1002/sim.2331, 16217841.